Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial

Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.

1988 • 241 citations

Replacement of DHEA in Aging Men and Women

1995 • 239 citations

Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women

1993 • 212 citations

Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood.

1995 • 166 citations

Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment.

1995 • 135 citations

Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.

1996 • 112 citations

Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women

1995 • 77 citations

Dehydroepiandrosterone (DHEA) and aging

1997 • 70 citations

Postmenopausal steroid replacement with micronized dehydroepiandrosterone: Preliminary oral bioavailability and dose proportionality studies

1992 • 60 citations

Dehydroepiandrosterone (DHEA) and aging

1995 • 47 citations

Delivery of dehydroepiandrosterone to premenopausal women: Effects of micronization and nonoral administration

1996 • 38 citations

Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs

1993 • 38 citations

Dehydroepiandrosterone Attenuates Study‐Induced Declines in Insulin Sensitivity in Postmenopausal Women^a

1995 • 29 citations

Metabolic Effects of 12-Month Percutaneous Dehydroepiandrosterone Replacement Therapy in Postmenopausal Women

1997 • 21 citations

DHEA Administration to Humans: Panacea or Palaver?

1995 • 19 citations

Cited By (0)

Loading...